Naproxen Hasco

Naproxen, the active ingredient in Naproxen Hasco, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a suppository for rectal use. It treats pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis and dysmenorrhea.

GNH USA supplies Naproxen Hasco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain in several musculoskeletal and gynecologic conditions.

- Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: decreases joint inflammation and stiffness. - Dysmenorrhea: relieves menstrual cramps and associated discomfort. - Acute pain: provides short‑term relief for mild to moderate pain episodes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dyspepsia: indigestion or heartburn. - Abdominal pain: cramping or discomfort. - Headache: transient pressure sensation. - Dizziness: light‑headed feeling. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or failure. - Cardiovascular events such as myocardial infarction. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic dysfunction or elevated liver enzymes. - Anaphylaxis: rare allergic shock.

Before using Naproxen, consider the following safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: especially in patients with kidney disease. - Evaluate cardiovascular risk: avoid in uncontrolled hypertension. - Use lowest effective dose: limit duration to the shortest necessary. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Naproxen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding potential. - ACE inhibitors: possible reduction in renal function. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Diuretics: risk of reduced renal perfusion. - Methotrexate: decreased clearance leading to toxicity. - Cyclosporine: enhanced nephrotoxic effect. - Beta‑blockers: potential attenuation of antihypertensive effect. - Corticosteroids: increased gastrointestinal ulcer risk.